These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 8067756)

  • 1. Inhibitory and bactericidal activities of levofloxacin against Mycobacterium tuberculosis in vitro and in human macrophages.
    Mor N; Vanderkolk J; Heifets L
    Antimicrob Agents Chemother; 1994 May; 38(5):1161-4. PubMed ID: 8067756
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro antimycobacterial activity of a new quinolone, levofloxacin (DR-3355).
    Saito H; Sato K; Tomioka H; Dekio S
    Tuber Lung Dis; 1995 Oct; 76(5):377-80. PubMed ID: 7495996
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antimicrobial activities of levofloxacin, clarithromycin, and KRM-1648 against Mycobacterium tuberculosis and Mycobacterium avium complex replicating within Mono Mac 6 human macrophage and A-549 type II alveolar cell lines.
    Sato K; Tomioka H; Akaki T; Kawahara S
    Int J Antimicrob Agents; 2000 Sep; 16(1):25-9. PubMed ID: 11185410
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effectiveness of ofloxacin against Mycobacterium tuberculosis and Mycobacterium avium, and rifampin against M. tuberculosis in cultured human macrophages.
    Crowle AJ; Elkins N; May MH
    Am Rev Respir Dis; 1988 May; 137(5):1141-6. PubMed ID: 3143278
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative antimicrobial activities of gatifloxacin, sitafloxacin and levofloxacin against Mycobacterium tuberculosis replicating within Mono Mac 6 human macrophage and A-549 type II alveolar cell lines.
    Sato K; Tomioka H; Sano C; Shimizu T; Sano K; Ogasawara K; Cai S; Kamei T
    J Antimicrob Chemother; 2003 Aug; 52(2):199-203. PubMed ID: 12865388
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro activities of levofloxacin used alone and in combination with first- and second-line antituberculous drugs against Mycobacterium tuberculosis.
    Rastogi N; Goh KS; Bryskier A; Devallois A
    Antimicrob Agents Chemother; 1996 Jul; 40(7):1610-6. PubMed ID: 8807049
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activities of bay Y 3118, levofloxacin, and ofloxacin alone or in combination with ethambutol against Mycobacterium avium complex in vitro, in human macrophages, and in beige mice.
    Bermudez LE; Inderlied CB; Kolonoski P; Wu M; Barbara-Burnham L; Young LS
    Antimicrob Agents Chemother; 1996 Mar; 40(3):546-51. PubMed ID: 8851568
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intracellular bactericidal activity of ciprofloxacin and ofloxacin against Mycobacterium tuberculosis H37Rv multiplying in the J-774 macrophage cell line.
    Rastogi N; Blom-Potar MC
    Zentralbl Bakteriol; 1990 Jun; 273(2):195-9. PubMed ID: 2119180
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activity and interactions of levofloxacin, linezolid, ethambutol and amikacin in three-drug combinations against Mycobacterium tuberculosis isolates in a human macrophage model.
    Rey-Jurado E; Tudó G; Soy D; González-Martín J
    Int J Antimicrob Agents; 2013 Dec; 42(6):524-30. PubMed ID: 24080479
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of antimycobacterial activity of grepafloxacin against Mycobacterium avium with that of levofloxacin: accumulation of grepafloxacin in human macrophages.
    Hirota M; Totsu T; Adachi F; Kamikawa K; Watanabe J; Kanegasaki S; Nakata K
    J Infect Chemother; 2001 Mar; 7(1):16-21. PubMed ID: 11406752
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro activity of ciprofloxacin, ofloxacin and levofloxacin against Mycobacterium tuberculosis.
    Akcali S; Surucuoglu S; Cicek C; Ozbakkaloglu B
    Ann Saudi Med; 2005; 25(5):409-12. PubMed ID: 16270765
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of activities of rifapentine and rifampin against Mycobacterium tuberculosis residing in human macrophages.
    Mor N; Simon B; Mezo N; Heifets L
    Antimicrob Agents Chemother; 1995 Sep; 39(9):2073-7. PubMed ID: 8540718
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bacteriostatic and bactericidal activities of benzoxazinorifamycin KRM-1648 against Mycobacterium tuberculosis and Mycobacterium avium in human macrophages.
    Mor N; Simon B; Heifets L
    Antimicrob Agents Chemother; 1996 Jun; 40(6):1482-5. PubMed ID: 8726023
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effect of levofloxacine on cell elements of the lung tissue and on the growth of drug resistant Mycobacteria tuberculosis].
    Sokolova GB; Semenova OV; Bogadel'nikova IV; Kunichan AD
    Antibiot Khimioter; 2002; 47(6):12-7. PubMed ID: 12422642
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro activity of the new difluorinated quinolone sparfloxacin (AT-4140) against Mycobacterium tuberculosis compared with activities of ofloxacin and ciprofloxacin.
    Rastogi N; Goh KS
    Antimicrob Agents Chemother; 1991 Sep; 35(9):1933-6. PubMed ID: 1952872
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intramacrophage passage of Mycobacterium tuberculosis and M. avium complex alters the drug susceptibilities of the organisms as determined by intracellular susceptibility testing using macrophages and type II alveolar epithelial cells.
    Tomioka H; Sato K; Sano C; Sano K; Shimizu T
    Antimicrob Agents Chemother; 2002 Feb; 46(2):519-21. PubMed ID: 11796367
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative antimycobacterial activities of ofloxacin, ciprofloxacin and grepafloxacin.
    Vacher S; Pellegrin JL; Leblanc F; Fourche J; Maugein J
    J Antimicrob Chemother; 1999 Nov; 44(5):647-52. PubMed ID: 10552981
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro susceptibility testing of levofloxacin and ofloxacin by microtiter plate Alamar blue against multidrug and non multidrug resistant Mycobacterium tuberculosis in Thailand.
    Pracharktam R; Angkananukool K; Vibhagool A
    J Med Assoc Thai; 2001 Sep; 84(9):1241-5. PubMed ID: 11800295
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro and in vivo activities of levofloxacin against Mycobacterium tuberculosis.
    JI B; Lounis N; Truffot-Pernot C; Grosset J
    Antimicrob Agents Chemother; 1995 Jun; 39(6):1341-4. PubMed ID: 7574527
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacies of liposome-encapsulated clarithromycin and ofloxacin against Mycobacterium avium-M. intracellulare complex in human macrophages.
    Onyeji CO; Nightingale CH; Nicolau DP; Quintiliani R
    Antimicrob Agents Chemother; 1994 Mar; 38(3):523-7. PubMed ID: 8203849
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.